Matthew Korenberg
Presidente presso LIGAND PHARMACEUTICALS INCORPORATED
Patrimonio netto: 6 M $ in data 30/04/2024
Posizioni attive di Matthew Korenberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Direttore operativo | 01/11/2022 | - |
Presidente | 01/11/2022 | - | |
Direttore Finanziario/CFO | 06/08/2015 | 01/11/2022 | |
VERNALIS | Direttore/Membro del Consiglio | 12/10/2018 | - |
QUALIGEN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2020 | - |
Independent Dir/Board Member | 01/01/2020 | - | |
PFENEX INC. | Direttore/Membro del Consiglio | 01/10/2020 | - |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding company. The company is based in Cambridge, UK. | Direttore/Membro del Consiglio | 12/10/2018 | - |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Direttore/Membro del Consiglio | - | - |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Research Ltd. develops pharmaceutical products. The company is based in London, UK. Founded in 1995. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Matthew Korenberg
Precedenti posizioni note di Matthew Korenberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | 01/07/1999 | 01/08/2013 |
Neurocircuit Therapeutics, Inc. | Direttore/Membro del Consiglio | 01/09/2013 | - |
Amministratore Delegato | 01/09/2013 | - | |
Fondatore | 01/09/2013 | - |
Formazione di Matthew Korenberg
University of Michigan | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Regno Unito | 4 |
Posizioni
Director/Board Member | 7 |
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 7 |
Finance | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
QUALIGEN THERAPEUTICS, INC. | Health Technology |
Aziende private | 7 |
---|---|
Neurocircuit Therapeutics, Inc. | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
Ligand UK Ltd.
Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding company. The company is based in Cambridge, UK. | Finance |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Health Technology |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Research Ltd. develops pharmaceutical products. The company is based in London, UK. Founded in 1995. | Health Technology |
- Borsa valori
- Insiders
- Matthew Korenberg
- Esperienza